Home › Funds › DAFNA Capital Management LLC › PRQR
DAFNA Capital Management LLC position in PRQR
PROQR THRAPEUTICS N V · Health Care
DAFNA Capital Management LLC reported holding 1,530,361 shares of PRQR (PROQR THRAPEUTICS N V) in its Q2 2026 13F filing — a position valued at US$2.8M, representing 0.54% of its reported portfolio and ranking #36 among its reported holdings. DAFNA Capital Management LLC has disclosed PRQR holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How DAFNA Capital Management LLC's PRQR position evolved
DAFNA Capital Management LLC first disclosed a stake in PRQR in Q3 2023 at 940,582 shares (US$1.2M). The position peaked in Q4 2024 at 1,567,561 shares, worth US$4.2M. Across 12 filings, DAFNA Capital Management LLC increased the stake 1 time(s), trimmed it 2 time(s) and left it unchanged 8 time(s). The most recent filing (Q2 2026) shows 1,530,361 shares valued at US$2.8M — a reduction of -37,200 shares quarter over quarter.. Notable position changes include a 73% increase in Q4 2024 (shares fell 50% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 940.58K | $1.22M | New |
| Q4 2023 | 940.58K | $1.86M | Hold |
| Q1 2024 | 905.58K | $2.07M | Reduce |
| Q2 2024 | 905.58K | $1.50M | Hold |
| Q3 2024 | 905.58K | $1.65M | Hold |
| Q4 2024 | 1.57M | $4.15M | Add |
| Q1 2025 | 1.57M | $2.08M | Hold |
| Q2 2025 | 1.57M | $3.20M | Hold |
| Q3 2025 | 1.57M | $3.34M | Hold |
| Q4 2025 | 1.57M | $3.17M | Hold |
| Q1 2026 | 1.57M | $2.54M | Hold |
| Q2 2026 | 1.53M | $2.85M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About PRQR and 13F data
PRQR (PROQR THRAPEUTICS N V) is a Health Care company. 35 other funds we track also report a position in PRQR — the largest reported positions include Privium Fund Management B.V. (US$10.3M), Ikarian Capital, LLC (US$6.4M), HEIGHTS CAPITAL MANAGEMENT, INC (US$5.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding PRQR
- Privium Fund Management B.V. 5.52M sh · $10.27M · Q2 2026
- Ikarian Capital, LLC 3.43M sh · $6.37M · Q2 2026
- HEIGHTS CAPITAL MANAGEMENT, INC 2.76M sh · $5.14M · Q2 2026
- Kynam Capital Management, LP 1.57M sh · $2.91M · Q2 2026
- Squadron Capital Management LLC 1.51M sh · $2.81M · Q2 2026
- M28 Capital Management LP 599.79K sh · $1.12M · Q2 2026
- Lynx1 Capital Management LP 521.41K sh · $969.83K · Q2 2026
- Monaco Asset Management SAM 244.49K sh · $454.75K · Q2 2026
More on DAFNA Capital Management LLC
FAQ
How long has DAFNA Capital Management LLC held PRQR?
DAFNA Capital Management LLC has disclosed PRQR holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is DAFNA Capital Management LLC's current position in PRQR?
As of Q2 2026, DAFNA Capital Management LLC holds 1.53M shares of PRQR (PROQR THRAPEUTICS N V), valued at $2.85M, representing 0.54% of its reported portfolio and ranking #36.
Has DAFNA Capital Management LLC been buying or selling PRQR?
In the latest 13F filing (Q2 2026), DAFNA Capital Management LLC reduced its position in PRQR. The position peaked in Q4 2024 at 1.57M shares.
Which other funds hold PRQR?
Other major institutional holders of PRQR include Privium Fund Management B.V., Ikarian Capital, LLC, HEIGHTS CAPITAL MANAGEMENT, INC, among 35 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.